华熙生物2025年净利2.91亿元，同比增长67.03%

Core Viewpoint - Huaxi Biological (688363) reported a significant decline in revenue for the fiscal year 2025, while achieving a notable increase in net profit, indicating a shift in business strategy and cost management [1] Financial Performance - The company achieved an operating revenue of approximately 4.217 billion yuan, representing a year-on-year decrease of 21.49% [1] - The net profit attributable to shareholders was approximately 291 million yuan, showing a year-on-year increase of 67.03% [1] Business Strategy - The growth in net profit is attributed to the company's continuous optimization of business structure and resource allocation [1] - A reduction in sales and management expenses compared to the previous year contributed to the improved profitability [1]